IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse
- 31 December 2006
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 8 (14-15) , 2880-2889
- https://doi.org/10.1016/j.micinf.2006.09.007
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Differential Immune Responses and Pulmonary Pathophysiology Are Induced by Two Different Strains of Respiratory Syncytial VirusThe American Journal of Pathology, 2006
- Persistent Effects Induced by IL-13 in the LungAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Endosomal Proteolysis by Cathepsins Is Necessary for Murine Coronavirus Mouse Hepatitis Virus Type 2 Spike-Mediated EntryJournal of Virology, 2006
- Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus GlycoproteinJournal of Virology, 2006
- Respiratory syncytial virus–induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergenJournal of Allergy and Clinical Immunology, 2003
- Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor ImmunosurveillanceThe Journal of Experimental Medicine, 2003
- Differences between IL-4Rα-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responsesCurrent Biology, 1998
- IL-13, IL-4Rα, and Stat6 Are Required for the Expulsion of the Gastrointestinal Nematode Parasite Nippostrongylus brasiliensisImmunity, 1998
- Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cellsImmunology Today, 1994
- Primary respiratory syncytial virus infection in miceJournal of Medical Virology, 1988